A comprehensive list of films that achieved significant commercial success by releasing exclusively in theaters during the period of widespread global lockdowns and restricted cinema capacity, highlighting the resilience of theatrical exhibition.
Get targeted exposure with custom position pinning and highlighted placement.
Released in May 2022, this blockbuster defied pandemic-era norms by securing massive box office returns despite ongoing health concerns. It became one of the highest-grossing films of the year, driven by word-of-mouth praise for its practical effects and nostalgic appeal.
Arriving in December 2022, this long-awaited sequel captivated global audiences with groundbreaking visual effects and immersive 3D experiences that justified the theatrical trip. It broke numerous records, proving that major tentpoles could still dominate the box office post-pandemic.
Although released slightly earlier, its extended run and record-breaking earnings occurred squarely within the pandemic window as theaters operated under strict restrictions. It became the fastest film to reach $1 billion globally, leveraging immense fan anticipation and multiverse storytelling.
As one of the first major studio tentpoles to release in the summer of 2021, it capitalized on the limited competition from other big-budget films. It grossed over $700 million worldwide, benefiting from pent-up demand for franchise action spectacles.
This Marvel Cinematic Universe entry debuted in July 2021 with a simultaneous theatrical and Premium VOD release, a novel approach for the studio. Despite controversy over the hybrid model, it performed strongly at the box office during a period of cautious audience return.
Christopher Nolan's complex thriller was one of the first major releases after initial pandemic shutdowns, requiring strict adherence to safety protocols. It grossed over $360 million globally, serving as a critical test case for the viability of theatrical releases during health crises.
Releasing in March 2021, this MonsterVerse entry was the first major studio film to hit theaters post-initial shutdowns. It succeeded globally with over $470 million in ticket sales, appealing to fans seeking spectacle during a time when many smaller films had been delayed.
Denis Villeneuve's sci-fi epic premiered in October 2021, gaining momentum as pandemic restrictions eased in many regions. Its visual grandeur and immersive sound design made it a prime candidate for the big screen, resulting in strong box office performance despite its long runtime.
The latest James Bond film faced multiple delays due to the pandemic before finally releasing in late 2021. It became one of the highest-grossing films of that year, driven by the franchise's enduring global popularity and the novelty of seeing Daniel Craig's final outing on the big screen.
This Chinese war epic dominated the global box office in 2021, becoming the highest-grossing film of the pandemic era worldwide. Its success was fueled by strong domestic support in China, where theaters had reopened earlier and operated with fewer restrictions than in the West.
Marvel's 2021 release was the first of the Phase 4 era, debuting in a market where audiences were gradually returning to cinemas. It performed well critically and commercially, helping to stabilize the MCU's momentum during a period of production and distribution uncertainty.
Releasing in November 2021, this Marvel film navigated the challenges of a shifting pandemic landscape with a simultaneous Disney+ Premier Access option. It grossed over $400 million globally, reflecting the mixed but recovering state of international box office markets.
This sequel arrived in October 2021, benefiting from a lighter pandemic load compared to its predecessor. It grossed over $500 million worldwide, demonstrating the enduring appeal of the anti-hero genre as audiences sought escapist entertainment in theaters.
Disney released this adventure film in July 2021, initially planning a day-and-date streaming release but opting for theatrical first. It performed modestly but positively, signaling Disney's willingness to experiment with release windows during the evolving pandemic landscape.
The 2021 reboot of the horror classic released in August, tapping into the audience appetite for communal scare experiences. It proved that mid-budget horror could thrive in theaters during the pandemic, offering a cost-effective yet impactful cinematic event for fans.
James Gunn's R-rated DC film released in August 2021, distinguishing itself in a crowded market by offering a unique, violent, and humorous tone. It garnered strong word-of-mouth and performed well at the box office, showcasing the appeal of auteur-driven superhero narratives.
This Warner Bros. release struggled at the box office but was significant for its day-and-date HBO Max launch. Its poor theatrical performance highlighted the challenges of competing with streaming options during the pandemic, influencing future release strategies for mid-tier family films.
Released in late 2021, this nostalgic sequel benefited from a strong legacy fanbase and a gradual return to normalcy in many theaters. It performed solidly at the box office, proving that family-friendly franchises could still generate significant theatrical revenue during the pandemic.
While initially limited, this biopic saw wider release in early 2022, capturing audiences interested in prestige dramas during a time when blockbusters dominated. Its critical acclaim and strong box office performance demonstrated that non-franchise content could still find success in theaters.
Released in December 2021, this controversial sequel faced mixed reviews but still managed to gross over $150 million domestically. Its release marked the end of a major franchise's hiatus, drawing in curious audiences despite the polarizing nature of its meta-narrative.